3SBio and its subsidiaries are engaged in the research, development, manufacture and distribution of pharmaceutical products in the People's Republic of China. Co. manufactures and distributes five types of biopharmaceutical products: EPIAO that is used to stimulate the production of red blood cells in patients with anemia; TPIAO for the treatment of chemotherapy-induced thrombocytopenia; Intefen for the treatment of carcinoma of the lymphatic or hematopoietic system and viral infectious diseases; Inleusin for the treatment of renal cell carcinoma, metastatic melanoma, thoratic fluid build-up caused by cancer and tuberculosis; and iron sucrose supplement designed to treat anemia.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.